SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Elicera Therapeutics Receives Chinese Notice of Allowance for ELC-401 Patent

Elicera Therapeutics AB says it received a China National Intellectual Property Administration notice of allowance for its ELC-401 patent.

Related stories